193 related articles for article (PubMed ID: 3435581)
1. Synthesis of some N-benzhydrylpiperazine derivatives as calcium antagonists.
Gubert S; Brasó MA; Sacristán A; Ortiz JA
Arzneimittelforschung; 1987 Oct; 37(10):1103-7. PubMed ID: 3435581
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of diphenylpiperazine N-type calcium channel inhibitors.
Pajouhesh H; Feng ZP; Ding Y; Zhang L; Pajouhesh H; Morrison JL; Belardetti F; Tringham E; Simonson E; Vanderah TW; Porreca F; Zamponi GW; Mitscher LA; Snutch TP
Bioorg Med Chem Lett; 2010 Feb; 20(4):1378-83. PubMed ID: 20117000
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological characterization of some benzazepinone derivatives.
Budriesi R; Rampa A; Bisi A; Fabbri G; Chiarini A; Valenti P
Arzneimittelforschung; 1995 Mar; 45(3):234-9. PubMed ID: 7741775
[TBL] [Abstract][Full Text] [Related]
4. Negative inotropic and calcium antagonistic activity of alkyl and arylalkyl phosphonates.
Bellucci C; Gualtieri F; Scapecchi S; Teodori E; Budriesi R; Chiarini A
Farmaco; 1989 Dec; 44(12):1167-91. PubMed ID: 2634406
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the structure of some 1,4-piperazine derivatives of aryloxyaminopropanos and their Ca-antagonistic activity.
Celková H; Sedlárová E; Cizmárik J
Pharmazie; 1997 Jun; 52(6):487-8. PubMed ID: 9260272
[No Abstract] [Full Text] [Related]
6. The inhibition by flunarizine of the norepinephrine-evoked contraction and calcium influx in rat aorta and mesenteric arteries.
Godfraind T; Dieu D
J Pharmacol Exp Ther; 1981 May; 217(2):510-5. PubMed ID: 7229987
[No Abstract] [Full Text] [Related]
7. Structure-activity relationship studies of xanthone and fluorenone-1,4-dihydropyridine-5-phosphonates.
Budriesi R; Rampa A; Bisi A; Fabbri G; Chiarini A; Valenti P
Arzneimittelforschung; 1996 Apr; 46(4):374-7. PubMed ID: 8740081
[TBL] [Abstract][Full Text] [Related]
8. Ca-antagonistic activity of some 1,4-piperazine derivatives.
Seginko J; Dobrocký P; Cagánová B
Pharmazie; 1995 May; 50(5):368-9. PubMed ID: 7604073
[No Abstract] [Full Text] [Related]
9. Facile synthesis and biological evaluation of 3,3-diphenylpropanoyl piperazines as T-type calcium channel blockers.
Choi YH; Baek du J; Seo SH; Lee JK; Pae AN; Cho YS; Min SJ
Bioorg Med Chem Lett; 2011 Jan; 21(1):215-9. PubMed ID: 21126876
[TBL] [Abstract][Full Text] [Related]
10. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
[TBL] [Abstract][Full Text] [Related]
11. New substituted 1,4-benzoxazine derivatives with potential intracellular calcium activity.
Bourlot AS; Sánchez I; Dureng G; Guillaumet G; Massingham R; Monteil A; Winslow E; Pujol MD; Mérour JY
J Med Chem; 1998 Aug; 41(17):3142-58. PubMed ID: 9703461
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Ca-antagonist activity of some benzhydryl derivatives.
Corsano S; Strappaghetti G; Di Domenico E; Brasili L; Picchio MT
Arch Pharm (Weinheim); 1989 Dec; 322(12):873-8. PubMed ID: 2619516
[TBL] [Abstract][Full Text] [Related]
13. The role of calcium in the action of drugs on vascular smooth muscle.
Godfraind T; Kaba A
Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196: 35-. PubMed ID: 4559548
[No Abstract] [Full Text] [Related]
14. [Diethyl benzylpiperazinomethyl and benzylpiperazinomethylbenzyl phosphonates as calcium inhibitors].
Younes S; Baziard-Mouysset G; Stigliani JL; Payard M; Bonnafous R; Tisne-Versailles J
J Pharm Belg; 1994; 49(2):119-25. PubMed ID: 8035302
[TBL] [Abstract][Full Text] [Related]
15. New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities.
Di Stilo A; Visentin S; Cena C; Gasco AM; Ermondi G; Gasco A
J Med Chem; 1998 Dec; 41(27):5393-401. PubMed ID: 9876109
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and pharmacological evaluation of reduced diastereoisomeric and quaternary ammonium derivatives of calcium antagonistic (methylenedioxy)indenes on the isolated rat aorta.
Witiak DT; Brumbaugh RJ; Heaslip RJ; Rahwan RG
J Med Chem; 1982 Apr; 25(4):452-6. PubMed ID: 7069724
[TBL] [Abstract][Full Text] [Related]
17. A new class of calcium antagonists. 2. Synthesis and biological activity of 11-[[4-[4-(4-fluorophenyl)-1-piperazinyl]butyryl]amino]-6,11- dihydrodibenzo[b,e]-thiepin maleate and related compounds.
Kurokawa M; Sato F; Fujiwara I; Hatano N; Honda Y; Yoshida T; Naruto S; Mastumoto J; Uno H
J Med Chem; 1991 Mar; 34(3):927-34. PubMed ID: 2002473
[TBL] [Abstract][Full Text] [Related]
18. [Effects of saponins from stems and leaves of Panax quinquefolium L. on the contraction of rabbit aortic strips].
Guan L; Yi X; Feng Q; Yang L
Zhongguo Zhong Yao Za Zhi; 1996 Jul; 21(7):431-4 inside backcover. PubMed ID: 9642398
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
[TBL] [Abstract][Full Text] [Related]
20. Contribution of the diethyl phosphonate group to a first approach of calcium-inhibiting activity: study of a series of various substituted 2-phenylbenzothiazoles.
Mouysset G; de Saqui-Sannes G; Younes S; Bellan J; Payard M; Tisne-Versailles J
Farmaco; 1990 Sep; 45(9):945-52. PubMed ID: 2282126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
